Related Experiment Video
Updated: May 6, 2026

Using a Pan-Viral Microarray Assay Virochip to Screen Clinical Samples for Viral Pathogens
Published on: April 27, 2011
Pooled screening for endogenous HHV-6 in subjects with coronary artery disease
Rie Koide1,2, Yoshie Nakashima3, Shohei Kojima1,2
1Genome Immunobiology RIKEN Hakubi Research Team, RIKEN Cluster for Pioneering Research and RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
Insights
Endogenous human herpesvirus 6 (eHHV-6) integration was screened in myocardial infarction (MI) patients. This study found eHHV-6 in 0.57% of MI patients, suggesting a potential link to coronary artery disease.
Area of Science:
- Genetics
- Virology
- Cardiology
Background:
- Endogenous human herpesvirus 6 (eHHV-6) is found in approximately 1% of the human population.
- eHHV-6 has been anecdotally linked to angina pectoris, a condition often indicative of coronary artery disease.
Purpose of the Study:
- To investigate the association between endogenous human herpesvirus 6 (eHHV-6) and myocardial infarction (MI).
- To determine the prevalence of eHHV-6 in a large cohort of MI patients.
Main Methods:
- Genomic DNA samples from 2976 MI patients were screened for eHHV-6 using multiplex quantitative PCR (qPCR).
- Identified eHHV-6 variants included eHHV-6A, eHHV-6B, and a solo-DR form of eHHV-6B.
Main Results:
- eHHV-6 was detected in 17 individuals (0.57%) within the MI patient cohort.
- Specific variants identified were 6 eHHV-6A, 10 eHHV-6B, and 1 solo-DR eHHV-6B.
- A non-statistically significant trend towards higher total cholesterol was observed in eHHV-6 positive individuals.
Conclusions:
- This large-scale screening confirms the presence of eHHV-6 in MI patients.
- The findings support further research into the role of eHHV-6 in cardiovascular diseases and other complex traits.
Abstract:
Endogenous human herpesvirus 6 (eHHV-6) is integrated into the genomes of approximately 1% of individuals and has been linked to angina pectoris which, like myocardial infarction (MI), generally denotes coronary artery disease. To investigate this association further, we screened 2976 genomic DNA samples from patients with MI for eHHV-6 using multiplex qPCR. We identified 17 eHHV-6-positive individuals (0.57%), including 6 with eHHV-6A, 10 with eHHV-6B, and 1 with the solo-DR form, an eHHV-6B variant characterized by the presence of a single direct repeat (DR) within the host genome. While subjects with eHHV-6 had slightly higher total cholesterol levels, this difference was not statistically significant after correction for multiple testing. Our large-scale screening demonstrates the prevalence of eHHV-6 in MI patients and highlights the potential of this approach for studying its impact on diseases and other complex traits.
More Related Videos
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Coronary Artery Disease IV: Preventive Measures
Acute Coronary Syndrome III: Diagnostic Studies

